Trials / Completed
CompletedNCT06492356
Impact of Tripolar Radiofrequency on Acne Scar
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Cairo University · Academic / Other
- Sex
- All
- Age
- 20 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to investigate the therapeutic efficacy of tripolar radiofrequency on acne scar
Detailed description
Acne scarring is a very troublesome complication associated with acne and is reported in as high as 95% of the patients, sometimes even with proper and prompt treatment. The visible depressed scars have been known to have a negative impact on patient's psychological well-being and quality of life. Post acne scarring can pose as a risk factor for depression, anxiety, and even suicide (Villani, 2020). There are a multitude of treatment options that are traditionally used for the treatment of acne scars including many ablative and non-ablative methods (Dogra, 2014). Furth more, the need of this study is developed from the lack in quantitative knowledge and information in the published studies which investigate the effect of tripollar RF This study will be designed to provide guidelines about the effect tripollar Radiofrequency on acne scars.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Tripolar radiofrequency therapy | Twenty patients underwent weekly TriPollar RF treatment, using a new RF technology with three or more electrodes. Glycerin was applied to the treatment area before and after each session, with the procedure lasting 15 minutes. The technology uses a sequence of electrical modulation to prevent overheating and requires no active cooling of the electrodes or skin. |
| DRUG | medical treatment | Twenty patients will receive medical treatment by dermatologist. |
Timeline
- Start date
- 2023-07-01
- Primary completion
- 2023-12-01
- Completion
- 2024-06-01
- First posted
- 2024-07-09
- Last updated
- 2024-07-11
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06492356. Inclusion in this directory is not an endorsement.